HomeInsightsStock Comparison

Biocon Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Biocon Ltd vs Dr Reddys Laboratories Ltd Stock Comparison

Last Updated on: Aug 03, 2025

Key Highlights

  • The Latest Trading Price of Biocon Ltd is ₹ 382.95 as of 01 Aug 15:30.
  • The P/E Ratio of Biocon Ltd changed from 43.4 on March 2020 to 40.4 on March 2025 . This represents a CAGR of -1.19% over 6 yearsThe P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 16.9 on March 2025 . This represents a CAGR of -6.69% over 6 years.
  • The Market Cap of Biocon Ltd changed from ₹ 32472 crore on March 2020 to ₹ 40964 crore on March 2025 . This represents a CAGR of 3.95% over 6 yearsThe Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 95465 crore on March 2025 . This represents a CAGR of 10.73% over 6 years.
  • The revenue of Biocon Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 revenue of ₹ 4474 crore. This represent the decline of -100% The revenue of Dr Reddys Laboratories Ltd for the Jun '25 is ₹ 8862 crore as compare to the Mar '25 revenue of ₹ 9056 crore. This represent the decline of -2.14%.
  • The ebitda of Biocon Ltd for the Jun '25 is ₹ 0 crore as compare to the Mar '25 ebitda of ₹ 1135 crore. This represent the decline of -100% The ebitda of Dr Reddys Laboratories Ltd for the Jun '25 is ₹ 2464 crore as compare to the Mar '25 ebitda of ₹ 2525 crore. This represent the decline of -2.43%.
  • The net profit of Biocon Ltd changed from ₹ 148.9 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1409 crore over 9 quarters. This represents a CAGR of 0.15% .
  • The Dividend Payout of Biocon Ltd changed from 69.72 % on March 2022 to 9.85 % on March 2025 . This represents a CAGR of -38.69% over 4 yearsThe Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 12.47 % on March 2025 . This represents a CAGR of -2.07% over 6 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Biocon Ltd

  • Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company.
  • Biocon, with its key business verticals of Generics, Biosimilars, Research Services and Novel Biologics, has leveraged its affordable innovation model and scientific capabilities to develop and manufacture both small and large molecules at global scale for the benefit of patients.
  • At present, Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in year 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw.
  • Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind.
  • In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International.

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's portfolio of products and services include Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

Biocon Ltd News Hub

News

Biocon edges higher after biologics arm launches autoimmune treatment drug Nepexto in Australia

Nepexto will be promoted by Generic Health, BBL's local partner and a leading provider of ...

Read more

23 Jul 2025 10:33

News

Biocon arm gets USFDA approval for insulin, Kirsty

Kirsty is biosimiler to Novolog. It is a rapid-acting human insulin analog indicated to im...

Read more

16 Jul 2025 08:32

News

Biocon Ltd gains for third straight session

Biocon Ltd gained for a third straight session today. The stock is quoting at Rs 390, up 2...

Read more

15 Jul 2025 13:05

News

Biocon schedules board meeting

Biocon will hold a meeting of the Board of Directors of the Company on 7 August 2025. Powe...

Read more

09 Jul 2025 10:55

News

Biocon gets MHRA UK approval for marketing Denosumab biosimilars 'Vevzuo' & 'Evfraxy'

Vevzuo is authorized for the prevention of skeletal related events (pathological fracture,...

Read more

07 Jul 2025 10:27

News

Biocon's biologics arm gets regulatory approval in EU for Denosumab biosimilars

Denosumab is a human monoclonal antibody that targets and binds a protein known as RANKL (...

Read more

03 Jul 2025 09:50

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories Ltd soars 0.02%, rises for fifth straight session

Dr Reddys Laboratories Ltd gained for a fifth straight session today. The stock is quoting...

Read more

29 Jul 2025 13:00

News

Dr Reddys Lab gains after Q1 PAT jumps 2% YoY to Rs 1,418 cr

Profit before tax (PBT) stood at Rs 1,905 crore in Q1 FY26, up 1.2% YoY EBITDA for the qua...

Read more

24 Jul 2025 12:17

News

Dr Reddy's Lab receives EIR from USFDA for Middleburgh API facility

In a regulatory filing, the company stated that the EIR was issued following a good manufa...

Read more

22 Jul 2025 09:53

News

Dr Reddys Laboratories Ltd slips for fifth straight session

Dr Reddys Laboratories Ltd is down for a fifth straight session today. The stock is quotin...

Read more

02 Jul 2025 13:35

News

Dr Reddys Laboratories to hold board meeting

Dr Reddys Laboratories will hold a meeting of the Board of Directors of the Company on 23 ...

Read more

24 Jun 2025 09:53

News

Dr Reddys Laboratories allots 10,685 equity shares under ESOP

Dr Reddys Laboratories has allotted 10,685 equity shares under ESOPs on 23 June 2025. Powe...

Read more

23 Jun 2025 18:31

SWOT Analysis Of Biocon Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Biocon Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Biocon Ltd and Dr Reddys Laboratories Ltd

Which company has a larger market capitalization, Biocon Ltd or Dr Reddys Laboratories Ltd?

Market cap of Biocon Ltd is 51,199 Cr while Market cap of Dr Reddys Laboratories Ltd is 101,785 Cr

What are the key factors driving the stock performance of Biocon Ltd and Dr Reddys Laboratories Ltd?

The stock performance of Biocon Ltd and Dr Reddys Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Biocon Ltd and Dr Reddys Laboratories Ltd?

As of August 3, 2025, the Biocon Ltd stock price is INR ₹382.95. On the other hand, Dr Reddys Laboratories Ltd stock price is INR ₹1219.6.

How do dividend payouts of Biocon Ltd and Dr Reddys Laboratories Ltd compare?

To compare the dividend payouts of Biocon Ltd and Dr Reddys Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions